Pasupati Fincap appoints Sagar Singh Rawat as company secretary
- Pasupati Fincap appoints Mr. Sagar Singh Rawat as Company Secretary and Compliance Officer
- Appointment effective September 10, 2026, per Board recommendation
- Mr. Rawat is an ICSI Associate Member with B.Com and LL.B degrees
- He holds no shareholding and has no relationship with existing directors

*this image is generated using AI for illustrative purposes only.
Pasupati Fincap Limited appointed Mr. Sagar Singh Rawat as Company Secretary and Compliance Officer effective September 10, 2026. The Board of Directors approved the appointment following a recommendation from the Nomination and Remuneration Committee.
The board meeting took place on Thursday, September 10, 2026, commencing at 3:30 pm and concluding at 4:00 pm. The company disclosed the outcome pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Appointment Details
Mr. Rawat assumes the role of Key Managerial Personnel. He holds an Associate Membership with the Institute of Company Secretaries of India (ICSI), bearing membership number A80550.
His educational background includes a Bachelor of Commerce and a Bachelor of Laws degree from Chaudhary Charan Singh University. The filing notes his professional experience in corporate law, securities law, corporate governance, and regulatory compliances.
| Particulars | Information |
|---|---|
| Name | Mr. Sagar Singh Rawat |
| Role | Company Secretary & Compliance Officer |
| Effective Date | September 10, 2026 |
| Shareholding | NIL |
| Director Relationship | Not related to any director |
The disclosure confirms that Mr. Rawat holds no shares in the company and is not related to any director of Pasupati Fincap Limited.
How might Mr. Rawat's specific expertise in securities law influence Pasupati Fincap's upcoming regulatory compliance strategies?
What impact could this leadership change have on the company's governance ratings or investor confidence in the near term?
Are there any pending regulatory investigations or compliance issues that this appointment aims to address proactively?































